JRCT ID: jRCT2080224696
Registered date:22/05/2019
Basic Information
Recruitment status | completed |
---|---|
Health condition(s) or Problem(s) studied | |
Date of first enrollment | 03/06/2019 |
Target sample size | 472 |
Countries of recruitment | Asia except Japan,Japan,North America,South America |
Study type | Interventional |
Intervention(s) | investigational material(s) Generic name etc : LY3298176 INN of investigational material : - Therapeutic category code : 249 Other hormone preparations (including antihormone preparations) Dosage and Administration for Investigational material : control material(s) Generic name etc : INN of investigational material : - Therapeutic category code : --- Other Dosage and Administration for Investigational material : |
Outcome(s)
Primary Outcome | confirmatory efficacy |
---|---|
Secondary Outcome | efficacy confirmatory safety exploratory pharmacokinetics |
Key inclusion & exclusion criteria
Age minimum | >= 18age old |
---|---|
Age maximum | Not applicable |
Gender | Both |
Include criteria | |
Exclude criteria |
Related Information
Primary Sponsor | Eli Lilly Japan K.K. |
---|---|
Secondary Sponsor | - |
Source(s) of Monetary Support | Eli Lilly Japan K.K. |
Secondary ID(s) | NCT03954834,JapicCTI-194771 |